Molecular basis of ‘hypoxic’ breast cancer cell radio-sensitization: phytochemicals converge on radiation induced Rel signaling

Radiation Oncology

Natarajan Aravindan³  Vibhudutta Awasthi¹  Terence S Herman³  Mohan Natarajan²  Sheeja Aravindan³ 

[1] Department of Pharmaceutical Sciences, University of Oklahoma Health Sciences Center, 800 NE 10th Street, Oklahoma City, OK, USA;Department of Pathology, University of Texas Health Sciences Center, San Antonio, TX, USA;Department of Radiation Oncology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA

关键词: Raspberry extract;    Resveratrol;    Genistein;    Neem leaf extract;    EF24;    Curcumin;    NFκB;    Phytochemicals;    Radio-sensitization;    Hypoxia;    Breast cancer;   

Others  :  1154505
DOI  :  10.1186/1748-717X-8-46

 received in 2012-06-26, accepted in 2013-02-25,  发布年份 2013

【 摘 要 】

Background

Heterogeneously distributed hypoxic areas are a characteristic property of locally advanced breast cancers (BCa) and generally associated with therapeutic resistance, metastases, and poor patient survival. About 50% of locally advanced BCa, where radiotherapy is less effective are suggested to be due to hypoxic regions. In this study, we investigated the potential of bioactive phytochemicals in radio-sensitizing hypoxic BCa cells.

Methods

Hypoxic (O2-2.5%; N2-92.5%; CO2-5%) MCF-7 cells were exposed to 4 Gy radiation (IR) alone or after pretreatment with Curcumin (CUR), curcumin analog EF24, neem leaf extract (NLE), Genistein (GEN), Resveratrol (RES) or raspberry extract (RSE). The cells were examined for inhibition of NFκB activity, transcriptional modulation of 88 NFκB signaling pathway genes, activation and cellular localization of radio-responsive NFκB related mediators, eNos, Erk1/2, SOD2, Akt1/2/3, p50, p65, pIκBα, TNFα, Birc-1, -2, -5 and associated induction of cell death.

Results

EMSA revealed that cells exposed to phytochemicals showed complete suppression of IR-induced NFκB. Relatively, cells exposed EF24 revealed a robust inhibition of IR-induced NFκB. QPCR profiling showed induced expression of 53 NFκB signaling pathway genes after IR. Conversely, 53, 50, 53, 53, 53 and 53 of IR-induced genes were inhibited with EF24, NLE, CUR, GEN, RES and RSE respectively. In addition, 25, 29, 24, 16, 11 and 21 of 35 IR-suppressed genes were further inhibited with EF24, NLE, CUR, GEN, RES and RSE respectively. Immunoblotting revealed a significant attenuating effect of IR-modulated radio-responsive eNos, Erk1/2, SOD2, Akt1/2/3, p50, p65, pIκBα, TNFα, Birc-1, -2 and −5 with EF24, NLE, CUR, GEN, RES or RSE. Annexin V-FITC staining showed a consistent and significant induction of IR-induced cell death with these phytochemicals. Notably, EF24 robustly conferred IR-induced cell death.

Conclusions

Together, these data identifies the potential hypoxic cell radio-sensitizers and further implies that the induced radio-sensitization may be exerted by selectively targeting IR-induced NFκB signaling.

【 授权许可】

   
2013 Aravindan et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

【 参考文献 】

• [1]Nordsmark M, Bentzen SM, Rudat V, Brizel D, Lartigau E, Stadler P, Becker A, Adam M, Molls M, Dunst J: Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiother Oncol 2005, 77:18-24.
• [2]Fyles A, Milosevic M, Hedley D, Pintilie M, Levin W, Manchul L, Hill RP: Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer. J Clin Oncol 2002, 20:680-687.
• [3]Ruan K, Song G, Ouyang G: Role of hypoxia in the hallmarks of human cancer. J Cell Biochem 2009, 107:1053-1062.
• [4]Gatenby RA, Kessler HB, Rosenblum JS, Coia LR, Moldofsky PJ, Hartz WH, Broder GJ: Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int J Radiat Oncol Biol Phys 1988, 14:831-838.
• [5]Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U, Vaupel P: Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 1996, 56:4509-4515.
• [6]Brizel DM, Sibley GS, Prosnitz LR, Scher RL, Dewhirst MW: Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 1997, 38:285-289.
• [7]Okunieff P, Hoeckel M, Dunphy EP, Schlenger K, Knoop C, Vaupel P: Oxygen tension distributions are sufficient to explain the local response of human breast tumors treated with radiation alone. Int J Radiat Oncol Biol Phys 1993, 26:631-636.
• [8]Lundgren K, Holm C, Landberg G: Hypoxia and breast cancer: prognostic and therapeutic implications. Cell Mol Life Sci 2007, 64:3233-3247.
• [9]Vaupel P, Schlenger K, Knoop C, Hockel M: Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements. Cancer Res 1991, 51:3316-3322.
• [10]Hohenberger P, Felgner C, Haensch W, Schlag PM: Tumor oxygenation correlates with molecular growth determinants in breast cancer. Breast Cancer Res Treat 1998, 48:97-106.
• [11]Overgaard J: Hypoxic radiosensitization: adored and ignored. J Clin Oncol 2007, 25:4066-4074.
• [12]Bendinelli P, Matteucci E, Maroni P, Desiderio MA: NF-kappaB activation, dependent on acetylation/deacetylation, contributes to HIF-1 activity and migration of bone metastatic breast carcinoma cells. Mol Cancer Res 2009, 7:1328-1341.
• [13]Tafani M, Schito L, Pellegrini L, Villanova L, Marfe G, Anwar T, Rosa R, Indelicato M, Fini M, Pucci B, Russo MA: Hypoxia-increased RAGE and P2X7R expression regulates tumor cell invasion through phosphorylation of Erk1/2 and Akt and nuclear translocation of NF-{kappa}B. Carcinogenesis 2011, 32:1167-1175.
• [14]Zhou D, Brown SA, Yu T, Chen G, Barve S, Kang BC, Thompson JS: A high dose of ionizing radiation induces tissue-specific activation of nuclear factor-kappaB in vivo. Radiat Res 1999, 151:703-709.
• [15]Aravindan N, Madhusoodhanan R, Ahmad S, Johnson D, Herman TS: Curcumin inhibits NFkappaB mediated radioprotection and modulate apoptosis related genes in human neuroblastoma cells. Cancer Biol Ther 2008, 7:569-576.
• [16]Madhusoodhanan R, Natarajan M, Veeraraghavan J, Herman TS, Aravindan N: NFkappaB activity and transcriptional responses in human breast adenocarcinoma cells after single and fractionated irradiation. Cancer Biol Ther 2009, 8:765-773.
• [17]Madhusoodhanan R, Natarajan M, Veeraraghavan J, Herman TS, Jamgade A, Singh N, Aravindan N: NFkappaB signaling related molecular alterations in human neuroblastoma cells after fractionated irradiation. J Radiat Res 2009, 50:311-324.
• [18]Baeuerle PA, Baltimore D: Hormonal Control Regulation of Gene Transcription. In Molecular Aspects of Cellular Regulation. Edited by Cohen P, Foulkes JG. North Holland, Amsterdam: Elsevier/ North Holland Biomedical Press Amsterdam; 1991:409-432.
• [19]Lenardo MJ, Baltimore D: NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control. Cell 1989, 58:227-229.
• [20]Neri A, Chang CC, Lombardi L, Salina M, Corradini P, Maiolo AT, Chaganti RS, Dalla-Favera R: B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50. Cell 1991, 67:1075-1087.
• [21]Higgins KA, Perez JR, Coleman TA, Dorshkind K, McComas WA, Sarmiento UM, Rosen CA, Narayanan R: Antisense inhibition of the p65 subunit of NF-kappa B blocks tumorigenicity and causes tumor regression. Proc Natl Acad Sci U S A 1993, 90:9901-9905.
• [22]Tozawa K, Sakurada S, Kohri K, Okamoto T: Effects of anti-nuclear factor kappa B reagents in blocking adhesion of human cancer cells to vascular endothelial cells. Cancer Res 1995, 55:4162-4167.
• [23]Ahmed KM, Li JJ: NF-kappa B-mediated adaptive resistance to ionizing radiation. Free Radic Biol Med 2008, 44:1-13.
• [24]McBride WH, Pajonk F, Chiang CS, Sun JR: NF-kappa B, cytokines, proteasomes, and low-dose radiation exposure. Mil Med 2002, 167:66-67.
• [25]Natarajan M, Mohan S, Konopinski R, Otto RA, Herman TS: Induced telomerase activity in primary aortic endothelial cells by low-LET gamma-radiation is mediated through NF-kappaB activation. Br J Radiol 2008, 81:711-720.
• [26]Sen P, Chakraborty PK, Raha S: Activation of p38MAPK by repetitive low-grade oxidative stress leads to pro-survival effects. Biochim Biophys Acta 2007, 1773:367-374.
• [27]Madhusoodhanan R, Natarajan M, Singh JV, Jamgade A, Awasthi V, Anant S, Herman TS, Aravindan N: Effect of black raspberry extract in inhibiting NFkappa B dependent radioprotection in human breast cancer cells. Nutr Cancer 2010, 62:93-104.
• [28]Veeraraghavan J, Natarajan M, Herman TS, Aravindan N: Curcumin-altered p53-response genes regulate radiosensitivity in p53-mutant Ewing's sarcoma cells. Anticancer Res 2010, 30:4007-4015.
• [29]Aravindan N, Veeraraghavan J, Madhusoodhanan R, Herman TS, Natarajan M: Curcumin regulates low-linear energy transfer gamma-radiation-induced NFkappaB-dependent telomerase activity in human neuroblastoma cells. Int J Radiat Oncol Biol Phys 2011, 79:1206-1215.
• [30]Veeraraghavan J, Aravindan S, Natarajan M, Awasthi V, Herman TS, Aravindan N: Neem leaf extract induces radiosensitization in human neuroblastoma xenograft through modulation of apoptotic pathway. Anticancer Res 2011, 31:161-170.
• [31]Veeraraghavan J, Natarajan M, Lagisetty P, Awasthi V, Herman TS, Aravindan N: Impact of curcumin, raspberry extract, and neem leaf extract on rel protein-regulated cell death/radiosensitization in pancreatic cancer cells. Pancreas 2011, 40:1107-1119.
• [32]Vilekar P, Awasthi S, Natarajan A, Anant S, Awasthi V: EF24 suppresses maturation and inflammatory response in dendritic cells. Int Immunol 2012, 24:455-464.
• [33]Veeraraghavan J, Natarajan M, Aravindan S, Herman TS, Aravindan N: Radiation-triggered tumor necrosis factor (TNF) alpha-NFkappaB cross-signaling favors survival advantage in human neuroblastoma cells. J Biol Chem 2011, 286:21588-21600.
• [34]Veeraraghavan J, Natarajan M, Herman TS, Aravindan N: Low-dose gamma-radiation-induced oxidative stress response in mouse brain and gut: regulation by NFkappaB-MnSOD cross-signaling. Mutat Res 2011, 718:44-55.
• [35]Bristow RG, Hill RP: Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability. Nat Rev Cancer 2008, 8:180-192.
• [36]Tang ZN, Zhang F, Tang P, Qi XW, Jiang J: Hypoxia induces RANK and RANKL expression by activating HIF-1alpha in breast cancer cells. Biochem Biophys Res Commun 2011, 408:411-416.
• [37]Royds JA, Dower SK, Qwarnstrom EE, Lewis CE: Response of tumour cells to hypoxia: role of p53 and NFkB. Mol Pathol 1998, 51:55-61.
• [38]Koong AC, Chen EY, Giaccia AJ: Hypoxia causes the activation of nuclear factor kappa B through the phosphorylation of I kappa B alpha on tyrosine residues. Cancer Res 1994, 54:1425-1430.
• [39]Aravindan N, Madhusoodhanan R, Natarajan M, Herman TS: Alteration of apoptotic signaling molecules as a function of time after radiation in human neuroblastoma cells. Mol Cell Biochem 2008, 310:167-179.
• [40]Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG: Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997, 275:218-220.
• [41]Tsai SH, Lin-Shiau SY, Lin JK: Suppression of nitric oxide synthase and the down-regulation of the activation of NFkappaB in macrophages by resveratrol. Br J Pharmacol 1999, 126:673-680.
• [42]Holmes-McNary M, Baldwin AS Jr: Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IkappaB kinase. Cancer Res 2000, 60:3477-3483.
• [43]Manna SK, Mukhopadhyay A, Aggarwal BB: Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J Immunol 2000, 164:6509-6519.
• [44]Knight DC, Eden JA: A review of the clinical effects of phytoestrogens. Obstet Gynecol 1996, 87:897-904.
• [45]Mills PK, Beeson WL, Phillips RL, Fraser GE: Cohort study of diet, lifestyle, and prostate cancer in Adventist men. Cancer 1989, 64:598-604.
• [46]Ali S, Varghese L, Pereira L, Tulunay-Ugur OE, Kucuk O, Carey TE, Wolf GT, Sarkar FH: Sensitization of squamous cell carcinoma to cisplatin induced killing by natural agents. Cancer Lett 2009, 278:201-209.
• [47]Alonso V, Perez-Martinez FC, Calahorra FJ, Esbrit P: Phytoestrogen modulation of bone-related cytokines and its impact on cell viability in human prostate cancer cells. Life Sci 2009, 85:421-430.
• [48]Banerjee S, Li Y, Wang Z, Sarkar FH: Multi-targeted therapy of cancer by genistein. Cancer Lett 2008, 269:226-242.
• [49]Baxa DM, Yoshimura FK: Genistein reduces NF-kappa B in T lymphoma cells via a caspase-mediated cleavage of I kappa B alpha. Biochem Pharmacol 2003, 66:1009-1018.
• [50]Dijsselbloem N, Goriely S, Albarani V, Gerlo S, Francoz S, Marine JC, Goldman M, Haegeman G: Vanden Berghe W: A critical role for p53 in the control of NF-kappaB-dependent gene expression in TLR4-stimulated dendritic cells exposed to Genistein. J Immunol 2007, 178:5048-5057.
• [51]Gadgeel SM, Ali S, Philip PA, Wozniak A, Sarkar FH: Genistein enhances the effect of epidermal growth factor receptor tyrosine kinase inhibitors and inhibits nuclear factor kappa B in nonsmall cell lung cancer cell lines. Cancer 2009, 115:2165-2176.
• [52]Gong L, Li Y, Nedeljkovic-Kurepa A, Sarkar FH: Inactivation of NF-kappaB by genistein is mediated via Akt signaling pathway in breast cancer cells. Oncogene 2003, 22:4702-4709.
• [53]Karmakar S, Roy Choudhury S, Banik NL, Ray SK: Combination of N-(4-hydroxyphenyl) retinamide and genistein increased apoptosis in neuroblastoma SK-N-BE2 and SH-SY5Y xenografts. Neuroscience 2009, 163:286-295.
• [54]Li Z, Li J, Mo B, Hu C, Liu H, Qi H, Wang X, Xu J: Genistein induces cell apoptosis in MDA-MB-231 breast cancer cells via the mitogen-activated protein kinase pathway. Toxicol In Vitro 2008, 22:1749-1753.
• [55]Singh-Gupta V, Zhang H, Banerjee S, Kong D, Raffoul JJ, Sarkar FH, Hillman GG: Radiation-induced HIF-1alpha cell survival pathway is inhibited by soy isoflavones in prostate cancer cells. Int J Cancer 2009, 124:1675-1684.
• [56]Garg AK, Buchholz TA, Aggarwal BB: Chemosensitization and radiosensitization of tumors by plant polyphenols. Antioxid Redox Signal 2005, 7:1630-1647.
• [57]Hermann RM, Fest J, Christiansen H, Hille A, Rave-Frank M, Nitsche M, Grundker C, Viereck V, Jarry H, Schmidberger H: Radiosensitization dependent on p53 function in bronchial carcinoma cells by the isoflavone genistein and estradiol in vitro. Strahlenther Onkol 2007, 183:195-202.
• [58]Katz J, Blake E, Medrano TA, Sun Y, Shiverick KT: Isoflavones and gamma irradiation inhibit cell growth in human salivary gland cells. Cancer Lett 2008, 270:87-94.
• [59]Raffoul JJ, Wang Y, Kucuk O, Forman JD, Sarkar FH, Hillman GG: Genistein inhibits radiation-induced activation of NF-kappaB in prostate cancer cells promoting apoptosis and G2/M cell cycle arrest. BMC Cancer 2006, 6:107. BioMed Central Full Text
• [60]Ravindranath MH, Muthugounder S, Presser N, Viswanathan S: Anticancer therapeutic potential of soy isoflavone, genistein. Adv Exp Med Biol 2004, 546:121-165.
• [61]Shin JI, Shim JH, Kim KH, Choi HS, Kim JW, Lee HG, Kim BY, Park SN, Park OJ, Yoon DY: Sensitization of the apoptotic effect of gamma-irradiation in genistein-pretreated CaSki cervical cancer cells. J Microbiol Biotechnol 2008, 18:523-531.
• [62]Wang Y, Raffoul JJ, Che M, Doerge DR, Joiner MC, Kucuk O, Sarkar FH, Hillman GG: Prostate cancer treatment is enhanced by genistein in vitro and in vivo in a syngeneic orthotopic tumor model. Radiat Res 2006, 166:73-80.
• [63]El-Rayes BF, Ali S, Ali IF, Philip PA, Abbruzzese J, Sarkar FH: Potentiation of the effect of erlotinib by genistein in pancreatic cancer: the role of Akt and nuclear factor-kappaB. Cancer Res 2006, 66:10553-10559.
• [64]Sarkar FH, Li Y: Mechanisms of cancer chemoprevention by soy isoflavone genistein. Cancer Metastasis Rev 2002, 21:265-280.
• [65]Sarkar FH, Li Y: Soy isoflavones and cancer prevention. Cancer Invest 2003, 21:744-757.
• [66]Sarkar FH, Li Y: The role of isoflavones in cancer chemoprevention. Front Biosci 2004, 9:2714-2724.
• [67]Subramaniam D, May R, Sureban SM, Lee KB, George R, Kuppusamy P, Ramanujam RP, Hideg K, Dieckgraefe BK, Houchen CW, Anant S: Diphenyl difluoroketone: a curcumin derivative with potent in vivo anticancer activity. Cancer Res 2008, 68:1962-1969.
• [68]Kasinski AL, Du Y, Thomas SL, Zhao J, Sun SY, Khuri FR, Wang CY, Shoji M, Sun A, Snyder JP: Inhibition of IkappaB kinase-nuclear factor-kappaB signaling pathway by 3,5-bis(2-flurobenzylidene)piperidin-4-one (EF24), a novel monoketone analog of curcumin. Mol Pharmacol 2008, 74:654-661.
• [69]Schmidt BM, Ribnicky DM, Lipsky PE, Raskin I: Revisiting the ancient concept of botanical therapeutics. Nat Chem Biol 2007, 3:360-366.
• [70]Newman DJ, Cragg GM: Natural products as sources of new drugs over the last 25 years. J Nat Prod 2007, 70:461-477.
• [71]Zong H, Wang F, Fan QX, Wang LX: Curcumin inhibits metastatic progression of breast cancer cell through suppression of urokinase-type plasminogen activator by NF-kappa B signaling pathways. Mol Biol Rep 2012, 39:4803-4808.
• [72]Liu Q, Loo WT, Sze SC, Tong Y: Curcumin inhibits cell proliferation of MDA-MB-231 and BT-483 breast cancer cells mediated by down-regulation of NFkappaB, cyclinD and MMP-1 transcription. Phytomedicine 2009, 16:916-922.
• [73]Pozo-Guisado E, Merino JM, Mulero-Navarro S, Lorenzo-Benayas MJ, Centeno F, Alvarez-Barrientos A, Fernandez-Salguero PM: Resveratrol-induced apoptosis in MCF-7 human breast cancer cells involves a caspase-independent mechanism with downregulation of Bcl-2 and NF-kappaB. Int J Cancer 2005, 115:74-84.
• [74]Seo HS, Choi HS, Choi HS, Choi YK, Um JY, Choi I, Shin YC, Ko SG: Phytoestrogens induce apoptosis via extrinsic pathway, inhibiting nuclear factor-kappaB signaling in HER2-overexpressing breast cancer cells. Anticancer Res 2011, 31:3301-3313.
• [75]Valachovicova T, Slivova V, Bergman H, Shuherk J, Sliva D: Soy isoflavones suppress invasiveness of breast cancer cells by the inhibition of NF-kappaB/AP-1-dependent and -independent pathways. Int J Oncol 2004, 25:1389-1395.